Schedule 13D ownership disclosure
Emmaus Life Sciences, Inc.
Security class unavailable · CUSIP: 29137T101
Event date: 2022-02-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 26.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-22-008120
- Form type
- SC 13D
- Filer
- Emmaus Life Sciences, Inc.
- CIK
- CIK 822370
- Filed
- Feb 17, 2022
- Reporting period
- Feb 09, 2022
- Description
- Schedule 13D beneficial ownership